[HTML][HTML] Lipoproteins and metabolites in diagnosing and predicting Alzheimer's disease using machine learning

F Wang, A Wang, Y Huang, W Gao, Y Xu… - Lipids in Health and …, 2024 - Springer
Background Alzheimer's disease (AD) is a chronic neurodegenerative disorder that poses a
substantial economic burden. The Random forest algorithm is effective in predicting AD; …

A community-based study identifying metabolic biomarkers of mild cognitive impairment and Alzheimer's disease using artificial intelligence and machine learning

A Yilmaz, I Ustun, Z Ugur, S Akyol… - Journal of …, 2020 - content.iospress.com
Background: Currently, there is no objective, clinically available tool for the accurate
diagnosis of Alzheimer's disease (AD). There is a pressing need for a novel, minimally …

Predicting Alzheimer's Disease with Interpretable Machine Learning

M Jia, Y Wu, C Xiang, Y Fang - Dementia and Geriatric Cognitive …, 2023 - karger.com
Introduction: This study aimed to develop novel machine learning models for predicting
Alzheimer's disease (AD) and identify key factors for targeted prevention. Methods: We …

Lipidomic markers for the prediction of progression from mild cognitive impairment to Alzheimer's disease

W Li, Y Zhou, Z Luo, R Tang, Y Sun, Q He… - The FASEB …, 2023 - Wiley Online Library
Dementia is a well‐known syndrome and Alzheimer's disease (AD) is the main cause of
dementia. Lipids play a key role in the pathogenesis of AD, however, the prediction value of …

RWD121 Developing a Risk Prediction Model for the Early Identification of Alzheimer's Disease (AD) in Elderly Patients

V Verma, V Dawar, S Bhargava, R Markan… - Value in …, 2023 - valueinhealthjournal.com
Objectives This study helps in predicting the incidence of AD based on multiple variables
that were identified during the prodromal phase. Identification and timely intervention delays …

[HTML][HTML] Prediction and classification of Alzheimer's disease based on combined features from apolipoprotein-E genotype, cerebrospinal fluid, MR, and FDG-PET …

Y Gupta, RK Lama, GR Kwon… - Frontiers in …, 2019 - frontiersin.org
Alzheimer's disease (AD), including its mild cognitive impairment (MCI) phase that may or
may not progress into the AD, is the most ordinary form of dementia. It is extremely important …

[HTML][HTML] Early-stage Alzheimer's disease prediction using machine learning models

C Kavitha, V Mani, SR Srividhya, OI Khalaf… - Frontiers in public …, 2022 - frontiersin.org
Alzheimer's disease (AD) is the leading cause of dementia in older adults. There is currently
a lot of interest in applying machine learning to find out metabolic diseases like Alzheimer's …

Relationship between Plasma Lipid Profile and Cognitive Status in Early Alzheimer Disease

C Peña-Bautista, L Álvarez-Sánchez… - International Journal of …, 2024 - mdpi.com
Alzheimer disease (AD) is a heterogeneous and complex disease in which different
pathophysiological mechanisms are involved. This heterogenicity can be reflected in …

Alzheimer's disease prediction model using demographics and categorical data

A Khan, M Usman - 2019 - learntechlib.org
Diagnosing Alzheimer's disease (AD) is usually difficult, especially when the disease is in its
early stage. However, treatment is most likely to be effective at this stage; improving the …

Deep learning analysis of UPLC-MS/MS-based metabolomics data to predict Alzheimer's disease

K Wang, LA Theeke, C Liao, N Wang, Y Lu… - Journal of the …, 2023 - Elsevier
Objective Metabolic biomarkers can potentially inform disease progression in Alzheimer's
disease (AD). The purpose of this study is to identify and describe a new set of diagnostic …